AOD-9604 5 mg

AOD-9604 (Anti-Obesity Drug-9604) is a synthetic bioactive peptide fragment derived from the C-terminus of Human Growth Hormone (hGH). Specifically, it corresponds to the amino acids 177–191 of the hGH polypeptide with an additional tyrosine at the N-terminal end. It is studied for its role in lipid metabolism, fat oxidation, and potential regenerative effects on connective tissues.

Research interest in AOD-9604 peptide has focused on lipolysis (fat breakdown), the inhibition of lipogenesis (fat formation), and metabolic regulation without the growth-promoting effects typically associated with full-length hGH. AOD-9604 mimics the lipolytic domain of hGH by stimulating the breakdown of adipose tissue while bypassing the growth hormone receptor that triggers IGF-1 production (Ng et al., 2000 — American Journal of Clinical Nutrition).

(Heffernan et al., 2001 — Journal of Endocrinology).

Current research applications include metabolic syndrome studies, fat oxidation pathway analysis, cartilage repair, osteoarthritis models, and bone remodeling investigations. Unlike conventional growth hormone therapies, AOD-9604 is investigated for its ability to regulate fat metabolism without inducing insulin resistance or systemic growth of other tissues, making it a critical subject for research into localized tissue regeneration (Kwon et al., 2012 — Molecular and Cellular Biochemistry).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling. COA included with every order. See also: Semaglutide, Tirzepatide, Retatrutide